Report Ocean has recently released its “Saudi Arabia Diabetes Drugs Market” Research Report for the years 2024-2032, presenting a comprehensive analysis of the market. This report extensively explores ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

Digital technologies loom large on the list—from the growing impact of artificial intelligence to the need for tech-enabled ...

In January 2020, spending on Ozempic, a Type 2 diabetes-indicated GLP-1, was just $4.6 million ... such as Wegovy and Zepbound. This combination of increased usage and expanded state coverage ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise. The FDA today ...

When is The Witcher 4 release date? CD Projekt Red initially confirmed the existence of a new game in The Witcher series via a press release in March 2022 and a title update in October 2022.

In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicines that include Ozempic, was cleared to treat moderate to severe OSA in individuals ...

In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicines that include Ozempic, was cleared to treat moderate to severe OSA in individuals with ...

A previous crop of weight-loss drugs, like Qsymia, a combination of older medicines not part of the GLP-1 class, and liraglutide, an earlier GLP-1 medicine sold under the brand name Saxenda ...